| Mrs Lori Marcia Leff, RPH | |
|
332 Raritan Ave, Highland Park, NJ 08904-2702 | |
| (732) 572-3773 | |
| (732) 572-6881 |
| Full Name | Mrs Lori Marcia Leff |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 332 Raritan Ave, Highland Park, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669659504 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RI18501 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lori Marcia Leff, RPH 332 Raritan Ave, Highland Park, NJ 08904-2702 Ph: (732) 572-3773 | Mrs Lori Marcia Leff, RPH 332 Raritan Ave, Highland Park, NJ 08904-2702 Ph: (732) 572-3773 |
News Archive
Pfizer Inc (NYSE: PFE) today announced that its agreement with Eisai to provide Aricept to patients suffering from Alzheimer's disease will continue without interruption. Under this redefined alliance, which resolves a previously disclosed dispute, Pfizer and Eisai will continue to co-promote Aricept in the U.S., Japan and key markets in Europe, and Pfizer will continue to have an exclusive license to sell Aricept in the other countries where it has rights.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
Unigene Laboratories, Inc. has announced a restructuring plan that includes a reduction in workforce to improve operational efficiencies and to better match resources with market demand and the Company's strategic objectives.
Thyroid carcinoma is the third most common tumor malignancy in children. This pediatric cancer shares several characteristics with adult thyroid cancer patients including common cellular subtypes that are papillary, follicular and medullary; a female to male ratio is approximately 6:1; and a cervical nodal disease that can be observed at the time of presentation in 30-60 percent in both papillary and follicular malignancies.
› Verified 9 days ago
Puja Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 332 Raritan Ave, Highland Park, NJ 08904 Phone: 732-572-3773 | |
Mr. Ivan Saiff, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Raritan Ave, Highland Park, NJ 08904 Phone: 732-545-0687 Fax: 732-545-1156 | |
Victoria Lopomo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 332 Raritan Ave, Highland Park, NJ 08904 Phone: 732-572-3773 | |
Vijay Torio Maktal, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Raritan Ave, Saiff Drugs, Highland Park, NJ 08904 Phone: 732-545-0687 Fax: 732-545-1156 | |
Erika Wong, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 332 Raritan Ave, Highland Park, NJ 08904 Phone: 732-572-3773 | |
Ms. Marianne Polunas, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Raritan Ave, Highland Park, NJ 08904 Phone: 732-545-0687 Fax: 732-545-1156 | |
Mr. Howard Mischne, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Raritan Ave, Highland Park, NJ 08904 Phone: 732-545-0687 Fax: 732-545-1156 |